JP2012507278A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012507278A5 JP2012507278A5 JP2011533932A JP2011533932A JP2012507278A5 JP 2012507278 A5 JP2012507278 A5 JP 2012507278A5 JP 2011533932 A JP2011533932 A JP 2011533932A JP 2011533932 A JP2011533932 A JP 2011533932A JP 2012507278 A5 JP2012507278 A5 JP 2012507278A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- rnaset2
- seq
- truncated
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19313408P | 2008-10-30 | 2008-10-30 | |
| US61/193,134 | 2008-10-30 | ||
| PCT/IL2009/001012 WO2010049933A1 (en) | 2008-10-30 | 2009-10-29 | Efficient expression of truncated human rnaset2 in e. coli |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012507278A JP2012507278A (ja) | 2012-03-29 |
| JP2012507278A5 true JP2012507278A5 (enExample) | 2012-12-13 |
Family
ID=41694413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011533932A Pending JP2012507278A (ja) | 2008-10-30 | 2009-10-29 | 短縮型ヒトrnaset2の大腸菌における効率的発現 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110207667A1 (enExample) |
| EP (1) | EP2346993A1 (enExample) |
| JP (1) | JP2012507278A (enExample) |
| AU (1) | AU2009309277A1 (enExample) |
| CA (1) | CA2739705A1 (enExample) |
| EA (1) | EA201100610A1 (enExample) |
| WO (1) | WO2010049933A1 (enExample) |
| ZA (1) | ZA201102615B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150009953A (ko) * | 2012-02-29 | 2015-01-27 | 에프. 호프만-라 로슈 아게 | 1→3 해독 프레임 이동의 감소 방법 |
| US11685935B2 (en) * | 2013-05-29 | 2023-06-27 | Cellectis | Compact scaffold of Cas9 in the type II CRISPR system |
| US20160340659A1 (en) | 2014-01-30 | 2016-11-24 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. | Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same |
| JP7082945B2 (ja) * | 2016-03-17 | 2022-06-09 | シーダーズ―シナイ メディカル センター | Rnaset2により炎症性腸疾患を診断する方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001021830A1 (en) * | 1999-09-24 | 2001-03-29 | Ambion, Inc. | Nuclease inhibitor cocktail |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| BRPI0516302A (pt) * | 2004-09-29 | 2008-09-02 | Yissun Res Dev Company Of The | rnase t2 humana recombinante e suas utilizações |
| US7608413B1 (en) * | 2005-03-25 | 2009-10-27 | Celera Corporation | Kidney disease targets and uses thereof |
-
2009
- 2009-10-29 AU AU2009309277A patent/AU2009309277A1/en not_active Abandoned
- 2009-10-29 US US13/126,494 patent/US20110207667A1/en not_active Abandoned
- 2009-10-29 JP JP2011533932A patent/JP2012507278A/ja active Pending
- 2009-10-29 EP EP09760011A patent/EP2346993A1/en not_active Withdrawn
- 2009-10-29 CA CA2739705A patent/CA2739705A1/en not_active Abandoned
- 2009-10-29 WO PCT/IL2009/001012 patent/WO2010049933A1/en not_active Ceased
- 2009-10-29 EA EA201100610A patent/EA201100610A1/ru unknown
-
2011
- 2011-04-08 ZA ZA2011/02615A patent/ZA201102615B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014253900B2 (en) | Engineered phenylalanine ammonia lyase polypeptides | |
| HRP20201973T1 (hr) | Ligandi modificirani kružnom permutacijom kao agonisti i antagonisti | |
| NZ587105A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| SA522433360B1 (ar) | L-أَسْباراجيناز مُعدل | |
| JP2011528896A5 (enExample) | ||
| JP2009268467A5 (enExample) | ||
| NZ603348A (en) | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| JP2015134796A5 (enExample) | ||
| EP4306123A3 (en) | Saposin-a derived peptides and uses thereof | |
| JP2015510393A5 (enExample) | ||
| NZ610620A (en) | Inhibitors of apoptosis and uses thereof | |
| JP2014529399A5 (enExample) | ||
| HRP20201081T1 (hr) | Inhibitorni peptidi porijeklom od trem-sličnog transkripta 1 (tlt-1) i njihove uporabe | |
| JP2017529326A5 (enExample) | ||
| IN2014DN09963A (enExample) | ||
| EP2589658A4 (en) | PARTIAL REGION POLYPEPTIDE OF REIC / DKK-3 PROTEIN | |
| JP2012102105A5 (enExample) | ||
| JP2012507278A5 (enExample) | ||
| IL269187B2 (en) | Dominant active yap, a hippo effector, induces chromatin accessiblity and cardiomyocyte renewal | |
| JP2015511599A5 (enExample) | ||
| JP2013531491A5 (enExample) | ||
| NZ703514A (en) | Fviii peptides for immune tolerance induction and immunodiagnostics | |
| HRP20161009T1 (hr) | Modificirani omci kao inhibitor komplementa | |
| MX367427B (es) | Gen insecticida variante axmi115 y metodos para utilizarlo. | |
| JP2013530965A5 (enExample) |